Table 2 Descriptive characteristics of patients enrolled in the study (n = 20)
Patient characteristic | No. |
|---|---|
Age, median (range) | 47 years (36–62) |
Tumor size, median (range) | 20 mm (5–40) |
Histopathology | |
Ductal carcinoma in situ (DCIS) | 4 (20 %) |
Invasive ductal carcinoma | 15 (75 %) |
Invasive lobular carcinoma | 1 (5 %) |
Axillary involvement in invasive carcinoma, n = 16 | 7 (43 %) |
Molecular subtype of invasive carcinoma, n = 16 | |
Luminal (A and B) | 11 (69 %) |
Her2 | 1 (6 %) |
Triple negative | 4 (25 %) |
V2R status known, n = 18 | |
Positive tumor expression | 6 (33 %) |
Type of surgery | |
Breast conserving surgery | 12 (60 %) |
Mastectomy | 8 (40 %) |
Postoperative adjuvant therapy | |
None (DCIS) | 4 (20 %) |
Cyclophosphamide-based chemotherapy | 6 (30 %) |
Radiotherapy | 3 (15 %) |
Chemoradiotherapy | 7 (35 %) |